Blog
Gaining post-market insights. Fast.
Utilizing the digital research expertise of IQVIA Consumer Health and ObvioHealth, a major multi-national European consumer health company was able to validate user experience with five of its nasal spray and allergy products in under 50 days and below budget.
Matt Stewart, Global Marketing Manager, IQVIA MedTech
Mar 02, 2023

Objective

A multi-national European pharmaceutical and consumer health company required clinical data to validate the safety and performance of five of its nasal spray and allergy products post CE-mark, in accordance with MDR 2017/745 Annex XIV Part B.

Methodology

IQVIA Consumer Health and ObvioHealth designed and conducted all five of these post-market clinical follow-up studies, which were successfully executing across multiple European countries. All study materials were translated into the primary languages spoken in each study’s location.

Digital recruitment for all five studies identified a target population that had used the nasal spray products in the past 6 months. Questionnaires were kept simple and intuitive to ensure high compliance rates and also allowed participants to report any adverse events or side effects experienced from using the products.

Results

The sponsor was able to gain valuable insights into participant use and satisfaction with the products as they planned for the future of the five brands. All recruitment was completed below projected budget, with the studies reaching completion before the targeted end date and within an average of 48 days.

For more information on how IQVIA Consumer Health can help you achieve powerful, post-market insights please contact: consumer.health@iqvia.com

Related solutions

Contact Us